Atria Investments Inc Boosts Stock Holdings in Cardinal Health, Inc. $CAH

Atria Investments Inc lifted its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 10.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 23,636 shares of the company’s stock after acquiring an additional 2,326 shares during the quarter. Atria Investments Inc’s holdings in Cardinal Health were worth $3,971,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also modified their holdings of CAH. Wellington Management Group LLP increased its position in shares of Cardinal Health by 1,666.7% during the first quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company’s stock worth $328,470,000 after acquiring an additional 2,249,241 shares during the period. JPMorgan Chase & Co. increased its position in shares of Cardinal Health by 40.0% during the first quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company’s stock worth $575,327,000 after acquiring an additional 1,193,983 shares during the period. Zurich Insurance Group Ltd FI increased its holdings in Cardinal Health by 4,935.9% in the first quarter. Zurich Insurance Group Ltd FI now owns 946,750 shares of the company’s stock valued at $130,434,000 after buying an additional 927,950 shares during the last quarter. Nuveen LLC acquired a new stake in Cardinal Health in the first quarter valued at $106,065,000. Finally, T. Rowe Price Investment Management Inc. acquired a new stake in Cardinal Health in the first quarter valued at $104,951,000. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Insider Activity

In related news, CEO Stephen M. Mason sold 41,575 shares of the firm’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the transaction, the chief executive officer owned 26,085 shares of the company’s stock, valued at $3,881,969.70. This trade represents a 61.45% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Ola M. Snow sold 28,151 shares of Cardinal Health stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.94, for a total value of $4,192,809.94. Following the completion of the sale, the insider directly owned 15,431 shares in the company, valued at $2,298,293.14. This represents a 64.59% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 271,676 shares of company stock valued at $40,489,525. Insiders own 0.12% of the company’s stock.

Analyst Ratings Changes

A number of research firms have weighed in on CAH. Citigroup raised their price target on Cardinal Health from $165.00 to $190.00 and gave the company a “neutral” rating in a research note on Friday. Wall Street Zen cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 2nd. Evercore ISI raised their price target on Cardinal Health from $190.00 to $220.00 and gave the company an “outperform” rating in a research note on Friday. Leerink Partners raised their price target on Cardinal Health from $187.00 to $211.00 in a research note on Friday. Finally, Wells Fargo & Company restated an “overweight” rating and issued a $185.00 price target (up from $183.00) on shares of Cardinal Health in a research note on Wednesday, August 13th. Twelve research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, Cardinal Health has a consensus rating of “Moderate Buy” and an average price target of $176.87.

Cardinal Health Stock Performance

CAH opened at $190.65 on Friday. The business’s 50-day simple moving average is $155.17 and its 200-day simple moving average is $154.51. Cardinal Health, Inc. has a one year low of $107.11 and a one year high of $197.67. The stock has a market capitalization of $45.29 billion, a P/E ratio of 29.56, a price-to-earnings-growth ratio of 1.39 and a beta of 0.71.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, October 30th. The company reported $2.55 EPS for the quarter, topping analysts’ consensus estimates of $2.22 by $0.33. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The business had revenue of $64.01 billion for the quarter, compared to analysts’ expectations of $59.41 billion. During the same quarter in the previous year, the firm earned $1.88 earnings per share. The business’s revenue was up 22.4% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. On average, equities research analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st were issued a dividend of $0.5107 per share. The ex-dividend date of this dividend was Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.1%. Cardinal Health’s dividend payout ratio (DPR) is currently 31.63%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.